Skip to main content
. 2024 Feb 25;115(4):1306–1316. doi: 10.1111/cas.16119

FIGURE 5.

FIGURE 5

Overview of molecular characteristics and potential therapeutic implications per subtype for muscle‐invasive bladder cancer (MIBC). ICB, immune checkpoint blockade.